Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Verdicts against social media companies carry consequences. But questions linger- When faith comes under fire: How Iran’s repression of religious minorities has increased
- The Best 10 Innovation Developments of the Year
- ‘Slender Man’ attacker back in custody. What we know about Morgan Geyser's disappearance and what happens next.
- Launch pad damaged as Russian rocket blasts off for space station, agency says
- Best Pizza Beating: What's Your #1?
- From Squid Game to Your Party! Six Entertaining Test Games That Will Have You in Join
- Two Indonesian UN peacekeepers killed in explosion in Lebanon
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
